Correlation Between Regenxbio and Opthea
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Opthea, you can compare the effects of market volatilities on Regenxbio and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Opthea.
Diversification Opportunities for Regenxbio and Opthea
Excellent diversification
The 3 months correlation between Regenxbio and Opthea is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Regenxbio i.e., Regenxbio and Opthea go up and down completely randomly.
Pair Corralation between Regenxbio and Opthea
Given the investment horizon of 90 days Regenxbio is expected to generate 0.64 times more return on investment than Opthea. However, Regenxbio is 1.57 times less risky than Opthea. It trades about 0.05 of its potential returns per unit of risk. Opthea is currently generating about 0.0 per unit of risk. If you would invest 723.00 in Regenxbio on December 30, 2024 and sell it today you would earn a total of 60.00 from holding Regenxbio or generate 8.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 85.48% |
Values | Daily Returns |
Regenxbio vs. Opthea
Performance |
Timeline |
Regenxbio |
Opthea |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Regenxbio and Opthea Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenxbio and Opthea
The main advantage of trading using opposite Regenxbio and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |